Can a better vitamin mix beat iron pills for anemia in pregnancy?

NCT ID NCT07665957

Not yet recruiting Disease control Sponsor: Sindh Institute of Child Health and Neonatology Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times

Summary

This study tests whether a daily multiple micronutrient supplement (MMS) works better than standard iron-folic acid (IFA) pills—or a combination of both—to raise hemoglobin levels and improve newborn health. Researchers will enroll 402 pregnant women in Pakistan and follow them through delivery. The goal is to find the best nutritional strategy to prevent anemia and support healthy births.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Multiple micronutrient supplement (MMS) and iron-folic acid (IFA)
What this could lead to: If MMS works better than IFA alone, it could lead to better pregnancy nutrition guidelines and reduce anemia and poor birth outcomes in low-resource settings.
What could go wrong: This is a small, early-stage trial in one country, so results may not apply elsewhere. Supplements may not significantly outperform standard care, and compliance can be low.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MATERNAL ANEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MATERNAL ANEMIA MATERNAL NUTRITION MICRONUTRIENT DEFICIENCY PREGNANCY OUTCOMES

More trials for these conditions

Other studies related to the condition(s) this trial covers.